The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis

Introduction:The platelet/lymphocyte ratio (PLR) has been studied frequently to determine the prognosis of cardiovascular diseases, chronic inflammatory diseases, and malignancies. Particularly, the PLR is an indicator of systemic inflammation and atherosclerosis. In this study, we aimed to evaluate...

Full description

Bibliographic Details
Main Authors: Fettah Eren, Ayşegül Demir, Güllü Eren
Format: Article
Language:English
Published: Galenos Yayinevi 2021-05-01
Series:İstanbul Medical Journal
Subjects:
Online Access: http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-platelet-lymphocyte-ratio-in-patients-with-sch/47289
id doaj-44f229b8ae8a4990a6b6df0d2521a752
record_format Article
spelling doaj-44f229b8ae8a4990a6b6df0d2521a7522021-04-28T07:14:15ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2021-05-0122216116710.4274/imj.galenos.2021.8997213049054The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and PrognosisFettah Eren0Ayşegül Demir1Güllü Eren2 University of Health Sciences Turkey, Konya Training and Research Hospital, Clinic of Neurology, Konya, Turkey University of Health Sciences Turkey, Konya Training and Research Hospital, Clinic of Neurology, Konya, Turkey Necmettin Erbakan University, Meram Faculty of Medicine, Department of Public Health, Konya, Turkey Introduction:The platelet/lymphocyte ratio (PLR) has been studied frequently to determine the prognosis of cardiovascular diseases, chronic inflammatory diseases, and malignancies. Particularly, the PLR is an indicator of systemic inflammation and atherosclerosis. In this study, we aimed to evaluate the value of the PLR and its relationship with mortality, cerebral hemorrhagic transformation, and short-term prognosis in patients with stroke treated with intravenous thrombolysis.Methods:Two hundred fifty stroke patients treated with intravenous thrombolysis were included in the study. Initial symptoms, comorbidities, and localization of cerebral ischemia were recorded. Disability was scored on the National Institutes of Health (NIH) stroke scale. At the 24th and 72nd hours after treatment, hemorrhagic transformation was evaluated by brain computed tomography. The in-hospital mortality rate was calculated. Patients were divided into groups according to the difference in the NIH stroke scale (between admission and discharge). Serum platelet and lymphocyte levels and PLR values were determined.Results:There were 128 (51.2%) female and 122 (48.8%) male patients included in the study. Their mean age was 71.88±12.36 years. The lymphocyte count was low and the PLR was high in patients with a high level of initial disability (p<0.01). The lymphocyte count was higher in patients with clinical improvement (p=0.023). The lymphocyte count was lower and the PLR was higher in patients who died (p<0.01). The platelet level was lower in patients with hemorrhagic transformation (p=0.024). The lymphocyte level and PLR were similar in the hemorrhagic transformation groups (p=0.156, p=0.675).Conclusion:In this study, it was determined that mortality is related to the PLR, and hemorrhagic transformation is related to platelet levels in patients with ischemic stroke treated with intravenous thrombolysis. http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-platelet-lymphocyte-ratio-in-patients-with-sch/47289 ischemic strokeintravenous thrombolysisplatelet/ lymphocyte ratio
collection DOAJ
language English
format Article
sources DOAJ
author Fettah Eren
Ayşegül Demir
Güllü Eren
spellingShingle Fettah Eren
Ayşegül Demir
Güllü Eren
The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
İstanbul Medical Journal
ischemic stroke
intravenous thrombolysis
platelet/ lymphocyte ratio
author_facet Fettah Eren
Ayşegül Demir
Güllü Eren
author_sort Fettah Eren
title The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
title_short The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
title_full The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
title_fullStr The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
title_full_unstemmed The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
title_sort platelet/lymphocyte ratio in patients with ischemic stroke treated with intravenous thrombolysis and its relationship with mortality, disability, and prognosis
publisher Galenos Yayinevi
series İstanbul Medical Journal
issn 2619-9793
2148-094X
publishDate 2021-05-01
description Introduction:The platelet/lymphocyte ratio (PLR) has been studied frequently to determine the prognosis of cardiovascular diseases, chronic inflammatory diseases, and malignancies. Particularly, the PLR is an indicator of systemic inflammation and atherosclerosis. In this study, we aimed to evaluate the value of the PLR and its relationship with mortality, cerebral hemorrhagic transformation, and short-term prognosis in patients with stroke treated with intravenous thrombolysis.Methods:Two hundred fifty stroke patients treated with intravenous thrombolysis were included in the study. Initial symptoms, comorbidities, and localization of cerebral ischemia were recorded. Disability was scored on the National Institutes of Health (NIH) stroke scale. At the 24th and 72nd hours after treatment, hemorrhagic transformation was evaluated by brain computed tomography. The in-hospital mortality rate was calculated. Patients were divided into groups according to the difference in the NIH stroke scale (between admission and discharge). Serum platelet and lymphocyte levels and PLR values were determined.Results:There were 128 (51.2%) female and 122 (48.8%) male patients included in the study. Their mean age was 71.88±12.36 years. The lymphocyte count was low and the PLR was high in patients with a high level of initial disability (p<0.01). The lymphocyte count was higher in patients with clinical improvement (p=0.023). The lymphocyte count was lower and the PLR was higher in patients who died (p<0.01). The platelet level was lower in patients with hemorrhagic transformation (p=0.024). The lymphocyte level and PLR were similar in the hemorrhagic transformation groups (p=0.156, p=0.675).Conclusion:In this study, it was determined that mortality is related to the PLR, and hemorrhagic transformation is related to platelet levels in patients with ischemic stroke treated with intravenous thrombolysis.
topic ischemic stroke
intravenous thrombolysis
platelet/ lymphocyte ratio
url http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-platelet-lymphocyte-ratio-in-patients-with-sch/47289
work_keys_str_mv AT fettaheren theplateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis
AT ayseguldemir theplateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis
AT gullueren theplateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis
AT fettaheren plateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis
AT ayseguldemir plateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis
AT gullueren plateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis
_version_ 1721503892981678080